
Healthcare Contract Development & Manufacturing Organization Market by Services (Clinical, Contract Development, Contract Manufacturing), End-User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Compani
Description
Healthcare Contract Development & Manufacturing Organization Market by Services (Clinical, Contract Development, Contract Manufacturing), End-User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small & Medium-Sized Pharmaceutical Companies) - Global Forecast 2024-2030
The Healthcare Contract Development & Manufacturing Organization Market size was estimated at USD 317.14 billion in 2023 and expected to reach USD 359.18 billion in 2024, at a CAGR 13.35% to reach USD 762.49 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Healthcare Contract Development & Manufacturing Organization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Healthcare Contract Development & Manufacturing Organization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Healthcare Contract Development & Manufacturing Organization Market, highlighting leading vendors and their innovative profiles. These include Baxter International, Inc., Cambrex Corporation, Catalent Inc., Corden Pharma International GmbH, EVER company group, Evonik Industries AG, Jabil, Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., MedPharm Ltd., Piramal Group, Recipharm AB, Sanmina Corporation, Siegfried-Group, and Thermo Fisher Scientific, Inc..
Market Segmentation & Coverage
This research report categorizes the Healthcare Contract Development & Manufacturing Organization Market to forecast the revenues and analyze trends in each of the following sub-markets:
Services
Clinical
Phase I
Phase II
Phase III
Phase IV
Contract Development
Preclinical
Bioanalysis & DMPK studies
Toxicology Testing
Contract Manufacturing
API/Bulk Drugs
Finished Dose Formulations
Medical Device
Class I
Class II
Class III
Laboratory Services
Analytical Services
Bioanalytical Services
End-User
Big Pharmaceutical Companies
Generic Pharmaceutical Companies
Small & Medium-Sized Pharmaceutical Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Healthcare Contract Development & Manufacturing Organization Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Healthcare Contract Development & Manufacturing Organization Market?
3. What are the technology trends and regulatory frameworks in the Healthcare Contract Development & Manufacturing Organization Market?
4. What is the market share of the leading vendors in the Healthcare Contract Development & Manufacturing Organization Market?
5. Which modes and strategic moves are suitable for entering the Healthcare Contract Development & Manufacturing Organization Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
196 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Healthcare Contract Development & Manufacturing Organization Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing outsourcing services by pharmaceutical companies
- 5.1.1.2. Rising need for generic drugs
- 5.1.1.3. Increasing demand for one-stop-shop contract development & manufacturing organization
- 5.1.2. Restraints
- 5.1.2.1. Compliance issues while outsourcing and regulatory and legal compliance
- 5.1.3. Opportunities
- 5.1.3.1. Increasing investment in pharmaceutical research & development
- 5.1.3.2. Emergence and commercialization of biological therapies
- 5.1.4. Challenges
- 5.1.4.1. Capacity utilization issues affecting the profitability of contract development & manufacturing organization
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Healthcare Contract Development & Manufacturing Organization Market, by Services
- 6.1. Introduction
- 6.2. Clinical
- 6.3.1. Phase I
- 6.3.2. Phase II
- 6.3.3. Phase III
- 6.3.4. Phase IV
- 6.3. Contract Development
- 6.4.1. Preclinical
- 6.4.2.1. Bioanalysis & DMPK studies
- 6.4.2.2. Toxicology Testing
- 6.4. Contract Manufacturing
- 6.5.1. API/Bulk Drugs
- 6.5.2. Finished Dose Formulations
- 6.5.3. Medical Device
- 6.5.4.1. Class I
- 6.5.4.2. Class II
- 6.5.4.3. Class III
- 6.5. Laboratory Services
- 6.6.1. Analytical Services
- 6.6.2. Bioanalytical Services
- 7. Healthcare Contract Development & Manufacturing Organization Market, by End-User
- 7.1. Introduction
- 7.2. Big Pharmaceutical Companies
- 7.3. Generic Pharmaceutical Companies
- 7.4. Small & Medium-Sized Pharmaceutical Companies
- 8. Americas Healthcare Contract Development & Manufacturing Organization Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Baxter International, Inc.
- 12.1.2. Cambrex Corporation
- 12.1.3. Catalent Inc.
- 12.1.4. Corden Pharma International GmbH
- 12.1.5. EVER company group
- 12.1.6. Evonik Industries AG
- 12.1.7. Jabil, Inc.
- 12.1.8. Laboratory Corporation of America Holdings
- 12.1.9. Lonza Group Ltd.
- 12.1.10. MedPharm Ltd.
- 12.1.11. Piramal Group
- 12.1.12. Recipharm AB
- 12.1.13. Sanmina Corporation
- 12.1.14. Siegfried-Group
- 12.1.15. Thermo Fisher Scientific, Inc.
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET RESEARCH PROCESS
- FIGURE 2. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET DYNAMICS
- FIGURE 7. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
- FIGURE 8. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 10. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. HEALTHCARE CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.